A single dose of intravenous human amniotic membrane-derived mesenchymal stem cells limits transmural infarction, reduces fibrosis size, and improves left ventricular systolic function in the myocardial ischemic/reperfusion model of rats
J.-W. Sung, Y.-T. Yeh, F.-S. Peng, Y.-C. Chen, A.-H. Li, S.-C. Wu
bioRxiv · Jul 30, 2022 · PreprintCell Biology